Core Insights - Financial giants are showing a bearish sentiment towards Arrowhead Pharma, with 50% of traders indicating bearish tendencies and only 37% bullish [1] - The average price target set by analysts for Arrowhead Pharma is $87.0, with various analysts maintaining different ratings and price targets [8][10] Options Trading Analysis - A total of 8 unusual trades were identified for Arrowhead Pharma, with 5 puts valued at $175,050 and 3 calls valued at $257,150 [1] - The major market movers are focusing on a price band between $62.5 and $77.5 for Arrowhead Pharma over the last three months [2] - The mean open interest for Arrowhead Pharma options trades is 878.14, with a total volume of 5,476.00 [3] Significant Options Trades - Notable trades include bullish call options at strike prices of $62.50 and $77.50, and bearish put options at $65.00 and $62.50, with total trades valued at $105.0K and $45.0K respectively [6] Company Overview - Arrowhead Pharmaceuticals Inc focuses on developing medicines for genetic diseases characterized by protein overproduction, targeting various conditions including cardiovascular and liver diseases [7] Analyst Ratings - Analysts from different firms have provided ratings for Arrowhead Pharma, with a Buy rating from A Securities at a target price of $81, RBC Capital maintaining an Outperform rating with a target of $80, and Piper Sandler holding an Overweight rating with a target of $100 [10]
Arrowhead Pharma Unusual Options Activity For January 05 - Arrowhead Pharma (NASDAQ:ARWR)